Advocacy intelligence hub — real-time data for patient organizations
Aerospace Center Hospital — NA
University of Southampton — PHASE3
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano — PHASE2
M.D. Anderson Cancer Center — PHASE1, PHASE2
M.D. Anderson Cancer Center — NA
Laval University — NA
Institut du Cancer de Montpellier - Val d'Aurelle — NA
Cybrexa Therapeutics — PHASE1, PHASE2
M.D. Anderson Cancer Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Faheez Mohamed, MBChB, MD, FRCS
Peritoneal Malignancy Unit Hampshire Hospitals NHS Foundation Trust
Kanwal P Raghav, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Stacey Cohen
Fred Hutch/University of Washington Cancer Consortium
Prakash Pandalai, MD, MD
University of Kentucky
📍 LEXINGTON, KY
Wim P Ceelen, MD, PhD, Prof
University Hospital, Ghent
Alexandre Brind'Amour, MD
Laval University